Summary Abstract: Despite technological advancements, REBOA is associated with significant risks due to complications of vascular access and ischemia-reperfusion. The inherent morbidity and mortality of REBOA is often compounded by coexisting injury and hemorrhagic shock. Additionally, the potential for REBOA-related injuries is exaggerated due to the growing number of interventions being performed by providers who have limited experience in endovascular techniques, inadequate resources, minimal training in the technique, and who are performing this maneuver in emergency situations. In an effort to ultimately improve outcomes with REBOA, we sought to compile a list of complications that may be encountered during REBOA usage. To address the current knowledge gap, we assembled a list of anecdotal complications from high-volume REBOA users internationally. More importantly, through a consensus model, we identify contributory factors that may lead to complications and deliberate on how to recognize, mitigate, and manage such events. An understanding of the pitfalls of REBOA and strategies to mitigate their occurrence is of vital importance to optimize patient outcomes. (C) 2017 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2y045NC
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Improvement in postoperative pain control by combined use of intravenous dexamethasone with intravenous dexmedetomidine after interscalene b...
-
Abstract Our molecular understanding of the cystic fibrosis transmembrane conductance regulator (CFTR)—the chloride channel that is mutate...
-
Publication date: February 2019 Source: The Journal of Emergency Medicine, Volume 56, Issue 2 Author(s): from Emergency Medicine via x...
-
http://bit.ly/2N5roLk
-
[ASAP] Directed Self-Assembly of Styrene-Methyl Acrylate Block Copolymers with Sub-7 nm Features via Thermal Annealing MacromoleculesDOI: 10...
-
Abstract Purpose Traumatic subclavian vascular injury (TSVI) is rare but often fatal. The precise diagnosis of TSVI remains challenging ...
-
Editorial introduction No abstract available Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipi...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου